↓ Skip to main content

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
1 patent
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
50 Mendeley
Title
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
Published in
Journal of Cancer Research and Clinical Oncology, April 2008
DOI 10.1007/s00432-008-0387-1
Pubmed ID
Authors

P. A. Fasching, B. Kollmannsberger, P. L. Strissel, B. Niesler, J. Engel, H. Kreis, M. P. Lux, S. Weihbrecht, B. Lausen, M. R. Bani, M. W. Beckmann, R. Strick

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Germany 2 4%
Switzerland 1 2%
Unknown 45 90%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 20%
Student > Bachelor 9 18%
Researcher 8 16%
Student > Master 5 10%
Student > Doctoral Student 2 4%
Other 8 16%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 19 38%
Agricultural and Biological Sciences 11 22%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Nursing and Health Professions 1 2%
Other 6 12%
Unknown 9 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2020.
All research outputs
#5,690,774
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#266
of 2,632 outputs
Outputs of similar age
#16,342
of 83,445 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#1
of 12 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,445 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.